Absci Corp

ABSI Nasdaq CIK: 0001672688

Company Information

Industry Services-Commercial Physical & Biological Research
SIC Code 8731
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
Business Address 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
Mailing Address 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
Phone (360) 949-1041
Fiscal Year End 1231
EIN 853383487

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13D/A Beneficial ownership amendment March 26, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
10-K Annual financial report March 24, 2026 View on SEC
4/A Insider transaction amendment March 16, 2026 View on SEC
4 Insider stock transaction report March 16, 2026 View on SEC
4/A Insider transaction amendment March 16, 2026 View on SEC
4/A Insider transaction amendment March 16, 2026 View on SEC
4/A Insider transaction amendment March 16, 2026 View on SEC
8-K Current report of material events March 6, 2026 View on SEC

Annual Reports

10-K March 24, 2026
  • Launched Origin-1, an AI platform capable of designing antibodies from scratch for previously unmapped biological targets.
  • Achieved clinical-stage status with lead drug candidate ABS-201 entering human safety trials.
View Analysis

Insider Trading

BUY 5 insiders 5 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8731)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.